Mawi DNA Technologies Announces New Distribution Partnership…
READ MORE
October 14, 2024 – We are thrilled to announce that Mawi DNA Technologies has officially partnered with GenoBank.io to tokenize our groundbreaking iSWAB® system as BioNFTs™️. With this partnership, Mawi becomes the first sample collection technology to join the Decentralized Science (DeSci) and Decentralized Physical…
READ MORE
Mawi DNA Partners with Tempus AI and Tally Health™ to compare flocked swabs from both Puritan® and Copan
October 7, 2024 – Customers frequently ask what swabs are compatible with our iSWAB® non-invasive sample collection technology. Although most swab types can be used with our system, including cotton, dacron, and rayon, we have found that flocked swabs provide the best overall result in…
READ MORE
Solena Ag and Mawi DNA Partner to Revolutionize Soil Health Analysis with Cutting-Edge Soil Sample Collection and Processing
January 4, 2024 – Solena Ag, a leader in soil health insights for sustainable agriculture, and Mawi DNA Technologies (Mawi DNA), a pioneer in high-integrity sample collection and storage, today announced a groundbreaking collaboration. This partnership will leverage Mawi DNA’s expertise in sample integrity preservation…
READ MORE
Mawi DNA Awarded Leading Innovators of Biosample Collection Technology 2022
The Global Health & Pharma (GH&P) Magazine awarded Mawi DNA Technologies with the 2022 Leading Innovators of Biosample Collection Technology Award. Mawi DNA is honored to be recognized for this achievement and continues to develop innovative technologies for universal sample collection. “I strongly believe that science is…
READ MOREMawi DNA’s Joint Venture: State-of-the-Art Manufacturing Facility in Morocco for African Market
Announcing Mawi DNA's joint venture with BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market. This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA's strategy and vision are centered around ensuring health needs…
READ MOREAchieve faster, more accurate COVID-19 results with the NextSWAB
Testing for infectious disease SARS-CoV-2 using the NextSWAB 100% medical-grade plastic molded swab – outperforms flocked swabs in many applications Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces its launch of a new product in response to…
READ MOREMawi DNA Technologies Awarded Two ISO Certifications
Hayward, CA - February 9, 2022 – Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications. Mawi developed and commercialized the iSWAB technology, an innovative…
READ MOREMawi DNA Technologies Supports UC San Diego for Back-To- School COVID Testing
Mawi is doing its part to help fight the global spread of COVID-19 HAYWARD, CA – October 25, 2021 – As the new school year begins, the University of California San Diego (UC San Diego) welcomes their students back to campus with a request to…
READ MOREWe Were Featured on NBC News!
https://youtu.be/wWzE63JOhSY We are proud to announce that our President and CTO, Dr. Bassam El-Fahmawi, PhD. was interviewed by NBC News Bay Area reporter Bigad Shaban regarding our iSWAB sample collection tube innovation. The primary purpose of the interview was to discuss its impact on corona…
READ MORETGFBI p.H626R Mutation: Late-Onset Lattice Corneal Dystrophy in Canadian Family
Article Abstract Within the over 70 reported transforming growth factor-beta–induced (TGFBI) corneal dystrophy mutations,1more than 40 are associated with lattice corneal dystrophy (LCD), subtypes I, III, IIIA, and IIIB according to the Human Gene Mutation Database (QIAGEN, Hilden, Germany). This is a follow-up investigation to…
READ MORE
